Background:
Color is an important characteristic of food, and over the last 15 years, more attention has been paid to natural colorants because of the rising demand for clean-label food products. Anthocyanins, which are a group of phytochemicals responsible for the purple, blue or red hues of many plants, offer a market advantage. In addition, anthocyanin-rich foods are associated with protection against cardiovascular disease, thrombosis, diabetes, cancer, microbial-based disorders, neurological disorders, and vision ailments. However, the real health value of anthocyanins, whether as a natural colorant or a functional ingredient, is dependent on the ultimate bioaccessibility and bioavailability in the human body. Many animal and human clinical studies revealed that, after intake of anthocyanin-rich foods or anthocyanin extracts, only trace amounts (< 1% of ingested content) of anthocyanins or their predicted metabolites were detected in plasma after a standard blood draw, which was indicative of low bioavailability of anthocyanins. Protein binding to anthocyanins is a strategy that has recently been reported to enhance the ultimate bioactivity, bioaccessibility, and bioavailability of anthocyanins as compared to anthocyanins delivered without a protein carrier.
Methods:
N/A - Review article.
Results:
Key findings from the reviewed literature indicate that only trace amounts (< 1% of ingested content) of anthocyanins or their predicted metabolites are detected in plasma after intake, demonstrating low bioavailability. In contrast, protein binding to anthocyanins has been reported to enhance the ultimate bioactivity, bioaccessibility, and bioavailability of anthocyanins compared to delivery without a protein carrier. The review addresses anthocyanin properties in food processing and digestion, anthocyanin–protein complexes used in food matrices, and changes in bioaccessibility and bioavailability when anthocyanins are bound with various plant or animal protein carriers.
Data Summary:
Quantitative evidence from many animal and human clinical studies shows that less than 1% of ingested anthocyanins or their predicted metabolites are detected in plasma after a standard blood draw, indicating low bioavailability. No additional quantitative results were provided in the excerpt.
Conclusions:
The review concludes that protein binding is a promising strategy to improve the bioaccessibility and bioavailability of anthocyanins, though challenges remain. Current evidence suggests that anthocyanin bioavailability may be far greater than initially assumed, and innovative food processing/encapsulation technologies, including protein binding, aim to improve stabilization in the gastrointestinal tract. The review summarizes challenges and prospects of this delivery system for anthocyanin pigments.
Practical Significance:
By using functional fruit- or vegetable-derived anthocyanins extracted from traceable natural sources as ingredients to naturally offset color lost in processed food products (including beverages, confections, dairy, and bakery goods), potential consumer backlash against artificial colorants is mitigated. The “health halo” associated with anthocyanins offers additional market advantage, and protein-binding approaches can enhance the real health value of these pigments by improving their bioaccessibility and bioavailability in food applications.